Abstract
Brain-lung-thyroid syndrome (BLTS) characterized by congenital hypothyroidism, respiratory distress syndrome, and benign hereditary chorea is caused by thyroid transcription factor 1 (NKX2-1/TTF1) mutations. We report the clinical and molecular characteristics of four cases presenting with primary hypothyroidism, respiratory distress, and neurological disorder. Two of the four patients presenting with the triad of BLTS had NKX2-1 mutations, and one of these NKX2-1 [c.890_896del (p.Ala327Glyfs*52)] is a novel variant. The third patient without any identified NKX2-1 mutations was a carrier of mitochondrial mutation; this raises the possibility of mitochondrial mutations contributing to thyroid dysgenesis. Although rare, the triad of congenital hypothyroidism, neurological, and respiratory signs is highly suggestive of NKX2-1 anomalies. Screening for NKX2-1 mutations in patients with thyroid, lung, and neurological abnormalities will enable a unifying diagnosis and genetic counseling for the affected families. In addition, identification of an NKX2-1 defect would be helpful in allaying the concerns about inadequate thyroxine supplementation as the cause of neurological defects observed in some children with congenital hypothyroidism.
Acknowledgments
We thank Dr. Barry. D. Lewis, the head of Clinical Biochemistry at Princess Margaret Hospital for Children, Perth, Western Australia for facilitating the genetic testing of these families.
Conflict of interest statement
The authors have nothing to disclose.
References
1. Damante G, Tell G, Di Lauro R. A unique combination of transcription factors controls differentiation of thyroid cells. Prog Nucleic Acid Res Mol Biol 2001;66:307–56.Search in Google Scholar
2. Zannini M, Avantaggiato V, Biffali E, Arnone MI, Sato K, et al. TTF-2, a new forkhead protein, shows a temporal expression in the developing thyroid which is consistent with a role in controlling the onset of differentiation. EMBO J 1997;16:3185–97.Search in Google Scholar
3. Guazzi S, Price M, De Felice M, Damante G, Mattei MG, et al. Thyroid nuclear factor 1 (TTF-1) contains a homeodomain and displays a novel DNA binding specificity. EMBO J 1990;9:3631–9.Search in Google Scholar
4. Pan Q, Li C, Xiao J, Kimura S, Rubenstein J, et al. In vivo characterization of the Nkx2.1 promoter/enhancer elements in transgenic mice. Gene 2004;331:73–82.Search in Google Scholar
5. Kimura S, Hara Y, Pineau T, Fernandez-Salguero P, Fox CH, et al. The T/ebp null mouse: thyroid-specific enhancer-binding protein is essential for the organogenesis of the thyroid, lung, ventral forebrain, and pituitary. Genes Dev 1996;10:60–9.Search in Google Scholar
6. Pohlenz J, Dumitrescu A, Zundel D, Martine U, Schonberger W, et al. Partial deficiency of thyroid transcription factor 1 produces predominantly neurological defects in humans and mice. J Clin Invest 2002;109:469–73.Search in Google Scholar
7. Olivieri A, Stazi MA, Mastroiacovo P, Fazzini C, Medda E, et al. A population-based study on the frequency of additional congenital malformations in infants with congenital hypothyroidism: data from the Italian Registry for Congenital Hypothyroidism (1991–1998). J Clin Endocrinol Metab 2002;87:557–62.Search in Google Scholar
8. Polak M, Sura-Trueba S, Chauty A, Szinnai G, Carre A, et al. Molecular mechanisms of thyroid dysgenesis. Horm Res 2004;62:14–21.Search in Google Scholar
9. Devriendt K, Vanhole C, Matthijs G, de Zegher F. Deletion of thyroid transcription factor-1 gene in an infant with neonatal thyroid dysfunction and respiratory failure. N Engl J Med 1998;338:1317–8.Search in Google Scholar
10. Krude H, Schutz B, Biebermann H, von Moers A, Schnabel D, et al. Choreoathetosis, hypothyroidism, and pulmonary alterations due to human NKX2-1 haploinsufficiency. J Clin Invest 2002;109:475–80.Search in Google Scholar
11. Willemsen MA, Breedveld GJ, Wouda S, Otten BJ, Yntema JL, et al. Brain-Thyroid-Lung syndrome: a patient with a severe multi-system disorder due to a de novo mutation in the thyroid transcription factor 1 gene. Eur J Pediatr 2005;164:28–30.Search in Google Scholar
12. Carre A, Szinnai G, Castanet M, Sura-Trueba S, Tron E, et al. Five new TTF1/NKX2.1 mutations in brain-lung-thyroid syndrome: rescue by PAX8 synergism in one case. Hum Mol Genet 2009;18:2266–76.Search in Google Scholar
13. Lapi P, Macchia PE, Chiovato L, Biffali E, Moschini L, et al. Mutations in the gene encoding thyroid transcription factor-1 (TTF-1) are not a frequent cause of congenital hypothyroidism (CH) with thyroid dysgenesis. Thyroid 1997;7:383–7.Search in Google Scholar
14. Gras D, Jonard L, Roze E, Chantot-Bastaraud S, Koht J, et al. Benign hereditary chorea: phenotype, prognosis, therapeutic outcome and long term follow-up in a large series with new mutations in the TITF1/NKX2-1 gene. J Neurol Neurosurg Psychiatry 2012;83:956–62.Search in Google Scholar
15. Doyle DA, Gonzalez I, Thomas B, Scavina M. Autosomal dominant transmission of congenital hypothyroidism, neonatal respiratory distress, and ataxia caused by a mutation of NKX2-1. J Pediatr 2004;145:190–3.Search in Google Scholar
16. Kusakabe T, Kawaguchi A, Hoshi N, Kawaguchi R, Hoshi S, et al. Thyroid-specific enhancer-binding protein/NKX2.1 is required for the maintenance of ordered architecture and function of the differentiated thyroid. Mol Endocrinol 2006;20:1796–809.Search in Google Scholar
17. Hamvas A, Deterding RR, Wert SE, White FV, Dishop MK, et al. Heterogeneous pulmonary phenotypes associated with mutations in the thyroid transcription factor gene NKX2-1. Chest 2013;144:794–804.Search in Google Scholar
18. Yuan B, Li C, Kimura S, Engelhardt RT, Smith BR, et al. Inhibition of distal lung morphogenesis in Nkx2.1(-/-) embryos. Dev Dyn 2000;217:180–90.Search in Google Scholar
19. Costa RH, Kalinichenko VV, Lim L. Transcription factors in mouse lung development and function. Am J Physiol Lung Cell Mol Physiol 2001;280:L823–38.Search in Google Scholar
20. Doriguzzi C, Palmucci L, Mongini T, Bresolin N, Bet L, et al. Endocrine involvement in mitochondrial encephalomyopathy with partial cytochrome c oxidase deficiency. J Neurol Neurosurg Psychiatry 1989;52:122–5.Search in Google Scholar
21. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 34–1987. A 30-year-old woman with an ocular motility disturbance, myopathy, and hypocalcemia. N Engl J Med 1987;317: 493–501.Search in Google Scholar
22. Balestri P, Grosso S. Endocrine disorders in two sisters affected by MELAS syndrome. J Child Neurol 2000;15:755–8.Search in Google Scholar
23. Lau KK, Yang SP, Haddad MN, Butani L, Makker SP. Mitochondrial encephalopathy with lactic acidosis and stroke-like episodes syndrome with hypothyroidism and focal segmental glomerulosclerosis in a paediatric patient. Int Urol Nephrol 2007;39:941–6.Search in Google Scholar
24. Kaufmann P, Engelstad K, Wei Y, Kulikova R, Oskoui M, et al. Protean phenotypic features of the A3243G mitochondrial DNA mutation. Arch Neurol 2009;66:85–91.Search in Google Scholar
25. Medda E, Olivieri A, Stazi MA, Grandolfo ME, Fazzini C, et al. Risk factors for congenital hypothyroidism: results of a population case-control study (1997–2003). Eur J Endocrinol 2005;153:765–73.Search in Google Scholar
26. Barnett CP, Mencel JJ, Gecz J, Waters W, Kirwin SM, et al. Choreoathetosis, congenital hypothyroidism and neonatal respiratory distress syndrome with intact NKX2-1. Am J Med Genet A 2012;158A:3168–73.Search in Google Scholar
27. Van Vliet G. Development of the thyroid gland: lessons from congenitally hypothyroid mice and men. Clin Genet 2003;63:445–55.Search in Google Scholar
28. Vassart G, Dumont JE. Thyroid dysgenesis: multigenic or epigenetic... or both? Endocrinology 2005;146:5035–7.Search in Google Scholar
©2014 by Walter de Gruyter Berlin Boston